SPARC slips after Q1 net loss widens

Sun Pharma Advanced Research Company dropped 1.91% to Rs 156.8 at 11:54 IST on the BSE after the company reported a net loss of Rs 94.19 crore in Q1 June 2019 as compared with a net loss of Rs 64.48 crore in Q1 June 2018.

The result was announced after market hours yesterday, 29 July 2019.

Meanwhile, the S&P BSE Sensex was up by 28.02 points or 0.07% to 37,714.39.

On the BSE, 1.47 lakh shares were traded in the counter so far compared with average daily volumes of 3.07 lakh shares in the past two weeks. The stock had hit a high of Rs 163.9 and a low of Rs 152 so far during the day. The stock hit a 52-week high of Rs 413.4 on 31 August 2018 and hit a 52-week low of Rs 107 on 9 June 2019.

 

The company's net sales increased 3% to Rs 17.32 crore in Q1 June 2019 over Q1 June 2018.

Sun Pharma Advanced Research Company (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The company works on innovation and new product development for global markets.

Powered by Capital Market - Live News